Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2025 09:15 ET | Source: Nutriband Inc.

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Dividend dates reminder
July 02, 2025 08:05 ET | Source: Nutriband Inc.

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Stock dividend
June 18, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Commercial Scale up complete for AVERSA
June 09, 2025 07:30 ET | Source: Nutriband Inc.

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

New Patent issuance
June 03, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference

noble conference announcement
June 02, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Q1 results
May 03, 2025 02:26 ET | Source: Citizens for Fair Governance

Many Citizens of Redington Beach Seeking Formal Complaints Regarding Alleged Retaliation by Local Officials

We The People Of Redington Beach Image REDINGTON BEACH, Fla., May 03, 2025 (GLOBE NEWSWIRE) -- Citizens for Fair Governance, a civil rights advocacy group representing many residents of...
April 30, 2025 07:30 ET | Source: Nutriband Inc.

Nutriband CEO Publishes Letter to Shareholders

2025 Letter to Shareholders
April 11, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Nutriband increases Patent protection with the addition of Macao
April 04, 2025 17:41 ET | Source: Nutriband Inc.

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an...

Next Page keyboard_arrow_right